Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MAGNA VICTORIA: Liraglutide for Cardiovascular Dysfunction in South Asian T2DM
NCT02660047Phase 4Completed
- Sponsor
- Leiden University Medical Center
- Start
- Aug 2015
- Primary completion
- Mar 2018
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of liraglutide in type 2 diabetes mellitus (T2DM), sponsored by Leiden University Medical Center. Started Aug 2015; status: completed.
02
Drugs
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02660047.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02660047.